HIPK2 overexpression relieves hypoxia/reoxygenation-induced apoptosis and oxidative damage of cardiomyocytes through enhancement of the Nrf2/ARE signaling pathway-Reference-Cited by-全球学者库

HIPK2 overexpression relieves hypoxia/reoxygenation-induced apoptosis and oxidative damage of cardiomyocytes through enhancement of the Nrf2/ARE signaling pathway

Published:2020-01 Issue: Volume:316 Page:108922
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Dang Xiaoyan,Zhang Rui,Peng Zhuo,Qin Yong,Sun Jiangli,Niu Zequn,Pei Honghong

Funder

Key Research and Development Program of Shaanxi Province

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference39 articles.

1. Heart disease and stroke statistics-2016 update: a report from the American Heart Association;Mozaffarian;Circulation,2016

2. Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials;Stergiopoulos;JAMA Intern. Med.,2014

3. Myocardial ischemia-reperfusion injury: a neglected therapeutic target;Hausenloy;J. Clin. Investig.,2013

4. Regulation of HIPK proteins by microRNAs;Conte;MicroRNA,2015

5. Identification of Hipk2 as an essential regulator of white fat development;Sjolund;Proc. Natl. Acad. Sci. U. S. A.,2014

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miR‐664a‐5p promotes experimental membranous nephropathy progression through HIPK2/Calpain1/GSα‐mediated autophagy inhibition;Journal of Cellular and Molecular Medicine;2024-01-07

2. Activating transcription factor 4 drives the progression of diabetic cardiac fibrosis;ESC Heart Failure;2023-06-08

3. miR-664a-5p promotes experimental membranous nephropathy progression through HIPK2/Calpain1/GSα-mediated autophagy inhibition;2023-05-26

4. HIPK2 as a Novel Regulator of Fibrosis;Cancers;2023-02-07

5. RNA methylation and cellular response to oxidative stress-promoting anticancer agents;Cell Cycle;2023-01-17